Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Aktionärsstruktur

Inhaber in %
Freefloat 99.85
The Vanguard Group, Inc. 9.66
Vanguard Group, Inc. (Subfiler) 9.22
State Street Corp. 4.61
Wellington Management Co. LLP 3.38
Vanguard Total Stock Market ETF 3.14
BlackRock Fund Advisors 2.84
Vanguard 500 Index Fund 2.47
BlackRock Institutional Trust Co. NA 2.22
Geode Capital Management LLC 2.19
Charles Schwab Investment Management, Inc. 1.45
Fidelity Management & Research Co. LLC 1.29
SPDR S&P 500 ETF Trust 1.19
Fidelity 500 Index Fund 1.18
Norges Bank (13F) 1.13

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 71’000 74’000 68’000 69’000 0
Umsatz pro Mitarbeiter in Mio. EUR 0.66 0.65 0.72 0.85 0.00

Bilanz (in Mio. EUR) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 27’483 27’764 30’266 35’722 0
Summe Anlagevermögen 53’257 58’770 72’815 77’976 0
Summe Aktiva 84’397 91’588 105’694 109’160 0

Bilanz (in Mio. EUR) - Passiva

2019 2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 27’350 33’453 34’631 31’985 0
Summe Fremdkapital 58’396 66’184 67’437 63’102 0
Summe Eigenkapital 26’001 25’404 38’257 46’058 0
Summe Passiva 84’397 91’588 105’694 109’160 0

Adresse

2000 Galloping Hill Road, 07033 Kenilworth
Telefon +1 (908) 740-4000
URL http://www.merck.com

Management

Allan Gabor
President-Asian-Pacific-BioPharma Business
Andre Musto
SVP & Head-Gbl Cardiometabolic & Endoc Franchise
Brooke Hinkson
Executive Director-Global Clinical Data Standards
Carol Bowden
Med Aff. Dir, Cardiovascular Metabolism, NorCal
Caroline A. Litchfield
Chief Financial Officer & Executive Vice President
Chirfi Guindo
Chief Marketing Officer-Human Health & SVP
Christine E. Seidman
Independent Director
Dalton E. Smart
Senior Vice President-Finance & Global Controller
Dave Williams
Chief Information & Digital Officer
Dean Y. Li
EVP & President-Merck Research Laboratories
Denise Williams
Vice President
Douglas M. Baker
Independent Director
Eric H. Rubin
Senior VP-Global Clinical Oncology
Fiona Hamilton Marshall
Senior VP & Global Head-Discovery Sciences
Inge G. Thulin
Independent Director
James Matteucci
Associate Director-State Government Affairs
Jannie Oosthuizen
President-Merck Human Health
Jennifer Zachary
Executive Vice President & General Counsel
Johanna Herrmann
Vice President-Global Communications
Joseph Romanelli
President-Human Health International
Kathy J. Warden
Independent Director
Kelly E. W. Grez
Secretary
Lisa LeCointe-Cephas
Senior VP, Chief Ethics & Compliance Officer
Mary Ellen Coe
Independent Director
Michael Klobuchar
Chief Strategy Officer & Executive Vice President
Milenko Cicmil
Director
Pamela J. Craig
Independent Director
Patricia Fiorello Russo
Independent Director
Paul B. Rothman
Independent Director
Peter C. Wendell
Independent Director
Peter Dannenbaum
Vice President-Investor Relations
Richard R. DeLuca
Executive Vice President & President-Animal Health
Risa J. Lavizzo-Mourey
Independent Director
Robert M. Davis
Chairman, President & Chief Executive Officer
Sanat Chattopadhyay
EVP & President-Merck Manufacturing Division
Stephen L. Mayo
Independent Director
Steven C. Mizell
Chief Human Resources Officer & Executive VP
Sylvia A. Ayler
Legal Director
Thomas Henry Glocer
Lead Independent Director

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen